Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral HDV-Insulin in Type 2 Diabetes
NCT00814294Phase 3Completed
- Sponsor
- Diasome Pharmaceuticals
- Start
- Dec 2008
- Primary completion
- Sep 2009
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of hdv-insulin in type 2 diabetes mellitus (T2DM), sponsored by Diasome Pharmaceuticals. Started Dec 2008; status: completed.
02
Drugs
hdv-insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00814294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00814294.